Published: Mar 15, 2026
Written by Klarity Editorial Team
Published: Mar 15, 2026

If you’re experiencing fatigue, decreased libido, mood changes, or other symptoms of low testosterone, you might be wondering: Can I get evaluated and treated for low T through telehealth? The short answer is yes—and it’s become more accessible than ever in 2025.
Thanks to expanded telehealth regulations and proven treatment options, many men are now managing low testosterone through virtual care. Here’s everything you need to know about getting legitimate, safe, and effective low T treatment online.
Low testosterone (hypogonadism) affects millions of American men, particularly those over 40. Symptoms can significantly impact quality of life, including:
Traditionally, diagnosing and treating low T required multiple in-person visits to a urologist or endocrinologist. Today, telehealth has made specialized care accessible to men who might otherwise struggle with access due to geography, scheduling, or provider shortages.
A legitimate telehealth low testosterone evaluation mirrors in-person care and typically includes:
Comprehensive medical history review – Your provider will ask about symptoms, overall health, medications, and any conditions that might contraindicate testosterone therapy (such as prostate cancer or severe heart disease)
Laboratory testing – You’ll need bloodwork to confirm low testosterone levels. Most telehealth providers either order labs through a local facility or accept recent results from your primary care doctor
Live consultation – A licensed healthcare provider (physician, nurse practitioner, or physician assistant) will review your history and labs via video or phone
Treatment plan – If appropriate, your provider will prescribe medication and establish a monitoring schedule
Ongoing follow-up – Responsible telehealth care includes regular check-ins to assess symptom improvement and monitor for side effects
Understanding the regulatory framework helps ensure you’re receiving legal, safe care:
For non-controlled medications (like Clomid/clomiphene): Federal law has never required an in-person visit before prescribing via telehealth. The Ryan Haight Act’s in-person examination requirement applies only to controlled substances, not standard medications.
For controlled substances (like testosterone injections): During the COVID-19 pandemic, the DEA suspended the requirement for an initial in-person visit before prescribing controlled medications via telehealth. This flexibility has been extended through December 31, 2025—the third extension as of November 2024.
What this means: As of late 2025, providers can legally prescribe both controlled and non-controlled low T treatments through telehealth without requiring you to visit an office first. However, this may change in 2026 if the DEA implements new permanent telemedicine regulations.
While federal law sets the baseline, state laws add their own requirements. Here’s what you need to know about key states:
States with minimal restrictions (California, Delaware, New Hampshire, New York): These states generally allow telehealth prescribing without mandating in-person visits for establishing care. New Hampshire actually removed its prior in-person requirement in August 2025, making it easier for residents to access telehealth hormone treatment.
States requiring periodic in-person evaluations (Alabama, Georgia): Some states mandate that if you’re receiving ongoing telehealth treatment, you must have an in-person exam within a certain timeframe:
States with hybrid approaches (Florida, Texas): These states allow telehealth prescribing but have specific rules about controlled substances and provider types. For instance, Florida permits telehealth prescribing of Schedule III-V controlled substances (which includes testosterone) but still prohibits purely telehealth-based Schedule II prescribing for most outpatient scenarios.
Important: Always verify that your telehealth provider is licensed in your state. Interstate telehealth prescribing without proper licensing is illegal and dangerous.
Clomiphene citrate, commonly known by the brand name Clomid, has become a frequently prescribed telehealth treatment for low testosterone. Here’s why:
What is Clomid? Originally FDA-approved for female fertility treatment, clomiphene is used off-label in men to boost natural testosterone production. It works by blocking estrogen receptors in the brain, which signals the body to produce more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), ultimately increasing testosterone production.
Advantages for telehealth patients:
Considerations: Because it’s an off-label use, you should understand that while Clomid is widely used and studied for male hypogonadism, it wasn’t specifically FDA-approved for this purpose. Discuss the evidence, benefits, and risks with your provider.
For men who aren’t good candidates for Clomid or who need more robust treatment, traditional testosterone replacement remains an option through telehealth:
Current telehealth status: As of late 2025, providers can prescribe testosterone through telehealth thanks to extended COVID-era flexibilities. However, because testosterone is a Schedule III controlled substance, this may become more restricted if federal rules change in 2026.
Legitimate telehealth providers follow established medical guidelines. According to the American Urological Association, diagnosing testosterone deficiency requires:
Red flag: Be wary of any telehealth service that offers prescriptions based solely on a questionnaire without requiring lab work or a live provider consultation. This doesn’t meet the standard of care and may indicate an illegitimate operation.
Most telehealth platforms handle lab work in one of two ways:
Testing should ideally be done in the morning (before 10 AM), when testosterone levels are naturally highest, to ensure accurate diagnosis.
Medical doctors (MDs and DOs) licensed in your state can evaluate and prescribe low testosterone treatments via telehealth nationwide, subject to state-specific telehealth rules.
NP prescribing authority varies significantly by state:
Full practice authority states (including New York, California, New Hampshire, Delaware): NPs can independently evaluate, diagnose, and prescribe low T medications without physician supervision.
Collaborative/supervisory states (including Texas, Florida, Alabama): NPs must work under a physician collaboration agreement. They can still prescribe low T treatments but within the scope of their agreement.
Restricted states (Georgia, Oklahoma): NPs cannot prescribe Schedule II controlled substances at all. However, they can still prescribe Clomid (non-controlled) and testosterone (Schedule III) under supervision.
PAs work under physician delegation in all states. Most states allow PAs to prescribe controlled substances including testosterone if it’s within their supervising physician’s scope of practice and the collaborative agreement permits it.
For patients: The provider type matters less than ensuring they are:
Most states require providers to check a Prescription Drug Monitoring Program database before prescribing controlled substances. This database tracks all controlled medication prescriptions and helps prevent:
For testosterone: If your provider prescribes testosterone (a controlled substance), they’re likely required to check your state’s PMP before the first prescription and periodically thereafter (requirements vary: every prescription, every 90 days, or every 4 months depending on the state).
For Clomid: Since it’s not a controlled substance, PMP checks aren’t required, though responsible providers will still review your medication history.
Legitimate low T treatment isn’t ‘set it and forget it.’ Expect your telehealth provider to:
At Klarity Health, our providers follow evidence-based monitoring protocols and coordinate with your primary care physician when appropriate, ensuring continuous, comprehensive care.
With the explosion of online men’s health services, not all telehealth platforms are created equal. Here’s how to identify legitimate providers:
Recent enforcement actions: In November 2024, federal prosecutors secured convictions against executives of a telehealth startup that prescribed 40 million Adderall pills without proper examinations. This was the first major federal prosecution targeting telehealth over-prescribing, signaling increased scrutiny of the industry. Choose providers who prioritize proper medical care over volume.
Without insurance, expect to pay:
Many insurance plans cover:
Medicare and telehealth: While Medicare’s COVID-era telehealth expansions for general visits were extended through 2024, coverage for 2025 depends on congressional action. Check current Medicare telehealth benefits or consult your provider.
At Klarity Health, we accept most major insurance plans and offer transparent cash-pay pricing for those without coverage or who prefer to pay out-of-pocket. Our team can verify your benefits before your appointment so there are no surprises.
You’ll meet with a licensed provider via video or phone. They’ll review your symptoms, medical history, and any risk factors. If you haven’t had recent testosterone testing, they’ll order lab work.
Visit a local lab for blood draws (usually two tests on separate mornings). Results typically return within a few days.
Your provider reviews your results. If low testosterone is confirmed and you’re a good candidate, they’ll discuss treatment options (Clomid vs. testosterone replacement), potential benefits and risks, and create a personalized plan.
Your prescription is sent electronically to your pharmacy of choice. Most providers start with conservative doses and adjust based on your response.
Expect a follow-up visit at:
Once your levels are optimized and stable, you’ll typically have check-ins every 6-12 months with annual lab work.
It depends. If your telehealth provider is licensed in your new state, you can continue care. If not, you’ll need to transition to a provider licensed in your new location. Some multi-state platforms (like Klarity Health) have providers licensed across multiple states, making transitions smoother.
Most telehealth providers can continue existing testosterone therapy. Bring your current treatment protocol and recent labs to your initial consultation. Your provider will review your regimen and may make adjustments or continue your current plan.
When done properly—with required lab work, live provider consultations, and regular monitoring—telehealth low T treatment follows the same clinical guidelines as in-person care. The convenience is different, but the medical quality should be equivalent.
Legitimate telehealth platforms use HIPAA-compliant systems to protect your health information. Your consultations, medical records, and prescriptions are confidential. Be cautious of platforms without clear privacy policies or secure communication systems.
While telehealth low T treatment is fully legal and accessible in late 2025, regulatory changes may be coming:
The DEA’s temporary COVID-era flexibilities for controlled substance prescribing (including testosterone) are currently set to expire December 31, 2025. The agency has proposed new permanent telemedicine regulations that may require:
What this means for patients:
Stay informed by checking with your telehealth provider about their preparedness for regulatory changes and how it might affect your care continuity.
If you’re experiencing symptoms of low testosterone, telehealth offers a convenient, legitimate pathway to diagnosis and treatment. The key is choosing a provider who:
At Klarity Health, we make low testosterone care accessible and straightforward. Our network of experienced, licensed providers offers:
✓ Same-day or next-day appointments in most states
✓ Transparent, affordable pricing (we accept insurance and cash pay)
✓ Comprehensive lab testing through national networks
✓ Evidence-based treatment options including Clomid and testosterone therapy
✓ Ongoing monitoring and support to optimize your results
✓ Licensed providers in your state ensuring legal, safe care
Don’t let low testosterone symptoms diminish your quality of life. Whether you’re in Texas, California, Florida, New York, or dozens of other states we serve, expert care is just a click away.
Ready to get started? Schedule your confidential low testosterone consultation with Klarity Health today. Take the first step toward feeling like yourself again.
Verified as of: December 17, 2025
DEA Rules Status: COVID-19 telehealth flexibilities for controlled substances extended through Dec 31, 2025 (third extension in Nov 2024). No new DEA final rule in effect yet (special registration pending). Non-controlled substance prescribing via telehealth remains unrestricted federally (Ryan Haight Act in-person rule applies only to controlled drugs).
States Verified: Texas (Nov 2025), California (Jul 2025), Florida (2022–2023 law changes), New York (May 2025), Georgia (Nov 2025), Alabama (Nov 2025), New Hampshire (Aug 2025).
Sources newer than 2024: 12 of 15 sources (80%) are 2025; remaining are late-2024 or authoritative 2023 updates.
⚠️ Flagged for follow-up: DEA’s proposed telemedicine regulations (special registration) – no final action as of Dec 2025. Monitor DEA for a likely 4th extension into 2026. Check state laws in 2026 for any newly effective telehealth or NP practice changes (e.g. California AB 1503 progress).
DEA and HHS Extend Telemedicine Flexibilities Through 2025 – U.S. Drug Enforcement Administration (November 15, 2024) – Official announcement of the third extension of COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2025. www.dea.gov
DEA Signals Extension of Telemedicine Flexibilities into 2026 – JD Supra/McDermott Will & Emery (November 19, 2025) – Expert legal analysis of DEA’s ongoing regulatory process and proposed special telemedicine registration requirements. www.jdsupra.com
Telehealth and ‘In-Person’ Visits: Multistate Update – JD Supra/Sheppard Mullin (August 15, 2025) – Comprehensive 50-state survey of telehealth prescribing requirements, including recent changes in California, New York, Florida, New Hampshire, and other key states. www.jdsupra.com
Testosterone Deficiency Guideline – American Urological Association (2018, reviewed 2024) – Clinical practice guidelines establishing diagnostic criteria for testosterone deficiency, including the requirement for two morning testosterone measurements below 300 ng/dL plus consistent symptoms. www.auanet.org
U.S. Jury Convicts Founder of ADHD Startup in Adderall Fraud Scheme – Reuters (November 19, 2024) – Report on first major federal prosecution of telehealth executives for improper prescribing practices, highlighting increased regulatory scrutiny of online prescribing services. www.reuters.com
Note: This article reflects regulations and medical guidelines current as of December 2025. Telehealth rules are evolving rapidly. Always verify current requirements with your provider and state medical board.
Find the right provider for your needs — select your state to find expert care near you.